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Abstract
A fundamental problem in medicine and biology is to assign states, e.g. healthy or diseased, to
cells, organs or individuals. State assignment or making a diagnosis is often a nontrivial and chal-
lenging process and, with the advent of omics technologies, the diagnostic challenge is becoming
more and more serious. The challenge lies not only in the increasing number of measured proper-
ties and dynamics of the system (e.g. cell or human body) but also in the co-evolution of multiple
states and overlapping properties, and degeneracy of states. We develop, from first principles, a
generic rational framework for state assignment in cell biology and medicine, and demonstrate its
applicability with a few simple theoretical case studies from medical diagnostics. We show how
disease-related statistical information can be used to build a comprehensive model that includes
the relevant dependencies between clinical and laboratory findings (signs) and diseases. In par-
ticular, we include disease-disease and sign-sign interactions. We then study how one can infer
the probability of a disease in a patient with given signs. We perform comparative analysis with
simple benchmark models to check the performances of our models. This first principles approach,
as we show, enables the construction of consensus diagnostic flow charts and facilitates the early
diagnosis of disease. Additionally, we envision that our approach will find applications in systems
biology, and in particular, in characterizing the phenome via the metabolome, the proteome, the
transcriptome, and the genome.
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I. INTRODUCTION
Human body as a whole or in part may adopt various states, like a Rubik’s Cube. Home-
ostatic mechanisms, medical interventions and aging all involve evolution from certain body
states to others. Similarly, evolution of states is commonly seen in cells that constitute
our bodies. Immune cells for example can manifest substantial plasticity and develop into
distinct phenotypes with different functions [2, 3]. Identifying dysfunctional states in cells
is in many ways similar to identifying diseases in organisms and is confronted by similar
difficulties. State assignment, as we describe below, is often a nontrivial and challenging
process and in many cases it is hard to diagnose the state of a cell or conditions of a pa-
tient. The progress in systems biology and availability of large data has made diagnostics
even more challenging. For instance, mass cytometric analysis of immune cells has led to
identification of many new cell subtypes (states) [4]. Metabolomic analysis of cells and body
fluids revealed a large number of biomarkers and disease subtypes [5]. There is a huge need
in the fields of cell biology, immunology, clinical sciences and pharmaceutical sciences for
approaches to identify states, assigning states and characterizing co-emerging or co-existing
states. Moreover, it is often important to be able to identify emerging states even before
they are fully evolved. From physics point of view, it is interesting to yield a generic un-
derstanding of the state assignment problem in cell biology or medicine (although specific
details might be crucial in each context in practice). Without loss of generality, in what fol-
lows we focus on medical diagnostics and draw a simple picture that captures many generic
aspects of assignment problems in medicine and systems cell biology.
Decision-making is at the heart of medicine. Decisions are made at various stages in
clinical practice, particularly during diagnostic investigations and when assigning the find-
ings to a disease [6, 7]. Diagnostic strategies are typically available in the form of clinical
algorithms and flow charts that define the sequence of actions to be taken to reach a diag-
nosis. The diagnosis itself is typically made based on consensus diagnostic criteria [8, 9]. In
addition, there are a number of clinical decision support systems and software systems that
are used to assign findings (symptoms and signs) to disease conditions. The most commonly
used technologies are WebMD Symptom Checker, Isabel Symptom Checker, DXplain and
Internist[10]. These algorithms compute the most likely disease that is associated with a
given set of findings by using only a small part of the existing probabilistic data on findings
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and diseases. Internist, which is one of the most sophisticated systems, relies on two pa-
rameters, the probability of a finding given a disease and the probability of a disease given
a finding [11]. These technologies inform us if a patient satisfies the criteria of a disease but
do not provide guidance on how to approach a patient and mostly ignore the interactions
between diseases.
Currently, we lack a solid conceptual framework for medical diagnostics. As a conse-
quence, there is no consensus on the diagnostic flow charts available today, and clinicians
differ widely in their approaches to patients. Here, we take a step towards solving this prob-
lem by formulating first principles medical diagnostics. We evaluate the performance of the
platform and discuss how one can optimize it. Using simple theoretical examples, we show
how including relevant statistical data and often-ignored inherent disease-disease linkages
significantly reduces diagnostic errors and mismanagement and enables the early diagnosis
of disease.
The problem of associating a subset of observed signs (clinical signs/symptoms and labo-
ratory data) with specific diseases was easy if we could assume the findings originate from a
single disease, we had clear demonstrations for the diseases, and inter-sign and inter-disease
interactions were negligible. In practice, however, we typically have no certain relationships
that connect signs to diseases, and one often must address interference effects of multiple
diseases; in the early stages of a disease, we do not even have sufficient findings to make a
definite decision [12–14]. There are a number of studies that have attempted to quantify
such dependencies under uncertainty and obtain estimations for the likelihood of diseases
given a subset of findings [11, 15–20]. An essential simplifying assumption in these studies
was that only one disease is behind the findings (exclusive diseases assumption). Among
recent developments, we should mention Bayesian belief networks, which provide a proba-
bilistic framework to study sign-disease dependencies [21–24]. These models are represented
by tables of conditional probabilities that show how the state of a node (sign or disease)
variable in an acyclic directed graph depends on the state of the parent variables. Here,
it is usually assumed that the signs are conditionally independent of one another given a
disease hypothesis and that diseases are independent of one another after marginalizing
over the sign variables (marginally independent diseases)[22]. In other words, there exist
no causal dependencies or interactions (directed links in the acyclic graph) that connect
the signs/diseases. In this study, however, we shall pursue a more principled approach to
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highlight the significance of direct disease-disease and sign-sign interactions (dependencies).
Evidences are rapidly growing to support the existence of such interactions [25–32]. Our
approach is of course computationally more expensive than the previous approaches, but it
shows how different types of interactions could be helpful in the course of diagnosis. Addi-
tionally, because of recent developments in related fields [33–36], we now have the necessary
concepts and tools to address difficulties in more sophisticated (realistic) problems of this
type. This study does not involve usage of real medical data, which is by the way fun-
damentally incomplete at this moment for such modeling; however, it provides a rationale
as to why certain often-neglected statistical information and medical data can be useful in
diagnosis and demonstrates that investments in collecting such data will likely pay off.
II. PROBLEM STATEMENT
Consider a set of ND binary variables D = {Da = 0, 1 : a = 1, . . . , ND}, where Da = 0, 1
shows the absence or presence of disease a. We have another set of NS binary variables
S = {Si = ±1 : i = 1, . . . , NS} to show the values of sign (symptom) variables.
Suppose we have the conditional probability of symptoms given a disease hypothesis,
P (S|D), and prior probability of diseases P0(D). Then, the joint probability distribution
of sign and disease variables reads as P (S;D) ≡ P (S|D)P0(D). We shall assume, for
simplicity, that the probability distributions describe the stationary state of the variables.
The distributions may be subject to environmental and evolutionary changes and may also
change in the course of the disease. Here, we limit our study to the time scales that are
smaller than the dynamical time scale of the model and leave the temporal dynamics for a
future study. In addition, we assume that we are given sufficient statistical data, e.g., the true
marginal probabilities Ptrue(Si, Sj|D), to reconstruct simple models of the true probability
distribution [37]. This is indeed the first part of our study: In Sec. IIIA, we propose
statistical models of sign and disease variables, and employ efficient learning algorithms to
compute the model parameters, given the appropriate data. Fortunately, recent advances in
machine learning and inference techniques enable us to work with models that involve very
large number of variables [36, 38–45].
Let us assume that a subset O = {i1, i2, . . . , iNO} of the sign variables has been observed
with values So, and size NO = |O|. We will use U for the remaining subset of unobserved
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signs with values which are denoted by Su. Then, the likelihood of disease variables given
the observed signs is:
L(D|So) ≡
∑
Su
P (S;D). (1)
The most likely diseases are obtained by maximizing the above likelihood:
DML = argmax
D
logL(D|So). (2)
Here, we are interested in the posterior probability marginals P (Da = 0, 1) of the disease
variables. The marginal probability P (Sj = ±1) of an unobserved sign, and the most likely
signs, are obtained from the following distribution:
M(Su|So) ≡
∑
D
P (S;D), SML = argmax
Su
logM(Su|So). (3)
The main task in the second part of our study is computation of the sign and disease marginal
probabilities
P (Da) ∝
∑
{Db:b6=a}
L(D|So), P (Sj) ∝
∑
{Sk :k∈U\j}
M(Su|So) j ∈ U. (4)
In general, computing the exact values of these marginals is a hard problem. However, one
can find highly accurate approximation methods developed in the artificial intelligence and
statistical physics communities to address such computationally difficult problems [33, 34,
46–49]. In Sec. III B, we propose an approximate message-passing algorithm for inferring
the above information in a large-scale problem.
Finally, the last and main part of our study is devoted to the problem of choosing a finite
sequence of unobserved signs for observation, which maximizes an appropriate objective
functional of the sequence of observations. In principle, the objective function should be
designed to approach the right diagnosis in a small number of observations. To this end, we
assign larger values to the objective function if the observations result to larger polarization
in the disease probabilities; obviously, it is easier to decide if disease a is present or not when
the marginal probability P (Da) is closer to 0 or 1 (more polarized). Computing such an
objective functional of the disease probabilities for a given sequence of observations is not an
easy task. We have to consider also the stochastic nature of the observations; we know the
sign probabilities P (Sj), but, we do not know a priori the value Sj of an unobserved sign,
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which is chosen for observation. To take into account this uncertainty, we shall work with
an objective function which is averaged over the possible outcomes of the observation. More
precisely, the above diagnosis problem is a multistage stochastic optimization problem, a
subject that has been extensively studied in the optimization community [35, 50–52].
Suppose we are to observe T ≤ NS−NO signs with an specified order OT ≡ {j1, . . . , jT };
there are (NS − NO)!/(T !(NS − NO − T )!) different ways of choosing T signs from NS −
NO ones, and T ! different orderings of the selected signs to identify such a sequence of
observations. Therefore, the number of possible sequences grows exponentially with T .
Add to this the computational complexity of working with an objective functional of the
sequence of observations, which has to be also averaged over the stochastic outcomes of the
observations. In Sec. IIIC, we present simple heuristic and greedy algorithms to address the
above problem, and leave a detailed study of the multistage stochastic optimization problem
for future.
III. RESULTS
A complete description of a collection of stochastic variables, like the sign and disease
variables, is provided by the joint probability distribution of the variables P (S;D). Having
the probability distribution (model) that describes a system of interacting variables does not,
however, mean that one can readily extract useful statistical information from the model. In
fact, both the model construction and the task of extracting information from the model are
computationally hard, with computation times that in the worst cases grow exponentially
with the number of involved variables [53–57]. In the following, we address the above sub-
problems in addition to the main problem of optimizing an appropriate objective functional
of observations, which are made during the course of diagnosis.
A. Learning the model: Maximum entropy principle
Let us assume that we are given the marginal probabilities Ptrue(Si, Sj|D) of the true
conditional probability Ptrue(S|D). Then, we use the maximum entropy principle to con-
struct an appropriate model P (S;D) ≡ P (S|D)P0(D) of the sign and disease variables
[58–60]. Here, P0(D) is the prior probability of the diseases depending on the age, gender,
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       Prior     Disease      Interaction     Sign      Leak         
P(S|D)
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α
P (D)0 P(S|0)
FIG. 1. The interaction graph of disease variables (left circles) and sign variables (right circles)
related by Ma one-disease and Mab two-disease interaction factors (middle squares) in addition to
interactions induced by the leak probability (right square) and the prior probability of diseases
(left square). In general, an interaction factor α = a, ab is connected to kα signs and lα diseases.
and other characteristics. In the following, we simply take a product prior distribution,
P0(D) =
∏
a P0(Da). In the absence of any prior information, the above probability dis-
tribution is uniform. The conditional probability P (S|D) represents all the sign/disease
interactions that are allowed by the maximum entropy principle,
P (S|D) = 1
Z(D)
exp
(∑
i
hi(D)Si +
∑
i<j
Jij(D)SiSj
)
. (5)
Here Z(D) is the normalization (or partition) function.
In practice, we are given only a small subset of the conditional probabilities, for instance,
Ptrue(Si, Sj|onlyDa) and Ptrue(Si, Sj|onlyDa, Db). The former is the probability that signs i
and j take values (Si = ±1, Sj = ±1) conditioned to the presence of disease a and the absence
of all other diseases. The latter conditional probabilities are defined similarly. Therefore,
we have to consider only interactions between a small number of disease variables. To this
end, we expand the model parameters,
hi(D) = h
0
i +
∑
a
haiDa +
∑
a<b
habi DaDb + · · · , (6)
Jij(D) = J
0
ij +
∑
a
JaijDa +
∑
a<b
Jabij DaDb + · · · , (7)
and keep only the leading terms of the expansion. Putting all together, given the above
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information, we rewrite
P (S|D) = 1
Z(D)
φ0(S)×
∏
a
φa(S|Da)×
∏
a<b
φab(S|Da, Db). (8)
Here, φ0 is responsible for the leak probabilities P (S|nodisease), to account for the missing
disease information and other sources of error [22, 24]. In the following, we assume that
local sign fields are sufficient to produce an accurate representation of the leak probabilities,
i.e., φ0 = exp(
∑
iK
0
i Si) . The other interaction factors, φa and φab, are present only if the
associated diseases are present; they are written in terms of local sign fields and two-sign
interactions:
φa = exp(Da[
∑
i
Kai Si +
∑
i<j
KaijSiSj]), (9)
φab = exp(DaDb[
∑
i
Kabi Si +
∑
i<j
Kabij SiSj]). (10)
Figure 1 shows a graphical representation of the model, which has Ma one-disease and
Mab two-disease interaction factors, each of which is connected to ka and kab sign variables,
respectively. From the above model, we obtain the simpler one-disease-one-sign (D1S1)
model in which we have only the one-disease factors (i.e., Mab = 0) and local sign fields (i.e.,
Kaij = 0). In a two-disease-one-sign model (D2S1), we have both the one- and two-disease
factors, but only the local sign fields. In the same way, we define the one-disease-two-
sign (D1S2) and two-disease-two-sign (D2S2) models. In the following, unless otherwise
mentioned, we shall work with the fully connected graphs with parameters: Ma = ND, ka =
NS for the D1S1 and D1S2 models, and Ma = ND,Mab = ND(ND − 1)/2, ka = kab = NS
for the D2S1 and D2S2 models. Moreover, the interaction factors in the D1S2 and D2S2
models include all the possible two-sign interactions in addition to the local sign fields.
To obtain the model parameters (K0i , K
a,ab
i , and K
a,ab
ij ), we start from the conditional
marginals Ptrue(Si|nodisease). This information is sufficient to determine the couplings K0i
from the following consistency equations:
Ptrue(Si|nodisease) =
∑
{Sj :j 6=i}
P (S|D = 0) ∀i. (11)
If we have Ptrue(Si, Sj |onlyDa), then in principle we can find Kai and Kaij from similar
consistency equations, assuming that we already know the K0i . Note that P (Si, Sj|onlyDa)
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is different from P (Si, Sj|Da), which is conditioned only on the value of disease a. In the
same way, having the Ptrue(Si, Sj|onlyDa, Db) allow us to find the couplings Kabi and Kabij ,
and so on. In general, the problem of finding the couplings from the above conditional
probabilities is computationally expensive. However, there are many efficient approximate
methods that enable us to find good estimations for the above couplings given the above
conditional probabilities [36, 38–41, 43, 45]. The reader can find more details about the
models in Appendix A, where we provide a very simple learning algorithm, which is based
on the Bethe approximation, for estimating the model parameters, given the above marginal
probabilities.
B. Computing the marginal probabilities: An approximate inference algorithm
Let us consider a simple benchmark model to check the performances of the above con-
structed models. As the benchmark, we take the true conditional probability
Ptrue(S|D) = 1
Ztrue(D)
e−H(S,S
∗(D)), (12)
where S∗(D) gives the symptoms of hypothesis D; we choose these symptoms randomly and
uniformly from the space of sign variables. Moreover, H(S,S∗(D)) ≡∑NSi=1(Si − S∗i (D))2/4
is the Hamming distance (number of different signs) of the two sign configurations. Note
that there is no sign-sign interaction in the above true model. Therefore, given the true con-
ditional marginals, we can exactly compute the model parameters, as described in Appendix
A.
For small numbers of sign/disease variables, we can use an exhaustive inference al-
gorithm to compute the exact marginal probabilities. Figure 2 displays the sensitivity
P (Si = +1|Da = 1) and specificity P (Si = −1|Da = 0) of the diseases [24], which have
been obtained by the one-disease-one-sing (D1S1) and two-disease-one-sing (D2S1) models
for a typical realization of the symptoms S∗(D) in the true model. As the figure shows, both
the probabilities are in average closer to the true values in the D2S1 model. This computa-
tion is intended to exhibit the high impact of two-disease interactions on the behavior of the
marginal probabilities. We will soon see that these large effects of interactions can indeed
play a constructive role also in the process of diagnosis.
To infer the marginal probabilities of the models for larger number of sign/disease vari-
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FIG. 2. Sensitivity, P (Si = +1|Da = 1), and specificity, P (Si = −1|Da = 0), of the D1S1 (open
circles) and D2S1 (filled circles) models versus the true values for a typical realization of the
exponential true model. The model parameters are obtained from the conditional marginals of the
true model. Here we have ND = 5 diseases, NS = 20 signs.
ables, we resort to the Bethe approximation and the Belief-Propagation algorithm [34, 47].
First, we suggest an approximate expression for the normalization function Z(D), which
appears in the denominator of the conditional probability distribution P (S|D). In words,
we consider this non-negative function of the diseases to be a probability measure, and we
approximate this measure by a factorized probability distribution, using its one- and two-
variable marginal probabilities (see Appendix B). This approximation enables us to employ
an efficient message-passing algorithm such as belief propagation for computing statistical
properties of the above models. As mentioned before, we shall assume that the prior prob-
ability P0(D) can also be written in an appropriate factorized form. The quality of our ap-
proximations depends very much on the structure of the interaction factors and the strengths
of the associated couplings in the models. The Bethe approximation is exact for interaction
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graphs that have a tree structure. This approximation is also expected to work very well
in sparsely connected graphs, in which the number of interaction factors (Ma,Mab) and the
number of signs associated with an interaction factor (ka, kab) are small compared with the
total number of sign variables. In Appendix B we display the relative errors in the marginal
signs/diseases probabilities that were obtained by the above approximate algorithm. The
time complexity of our approximate inference algorithm grows linearly with the number
of interaction factors and exponentially with the number of variables that are involved in
such interactions; with ND = 500, NS = 5000,Ma = 500,Mab = 1000, ka = 10, kab = 5, the
algorithm takes approximately one minute of CPU time on a standard PC to compute the
local marginals. We recall that the INTERNIST algorithm works with 534 diseases and
approximately 4040 signs (or manifestations), with 40740 directed links that connect the
diseases to the signs [22].
C. Optimization of the diagnosis process: A stochastic optimization problem
Suppose that we know the results of NO observations (medical tests), and we choose
another unobserved sign j ∈ U for observation. To measure the performance of our decision,
we may compute deviation of the disease probabilities from the neutral values (or ”disease
polarization”) after the observation:
DP (j) ≡
(
1
ND
∑
a
(
P (Da = 1)− 1
2
)2)1/2
. (13)
One can also add other measures such as the cost of observation to the above function.
In a two-stage decision problem, we choose an unobserved sign for observation, with the
aim of maximizing the averaged objective function E(j) ≡ 〈DP (j)〉O. Note that before
doing any real observation, we have access only to the probability of the outcomes P (Sj);
the actual or true value of an unobserved sign becomes clear only after the observation. That
is why here we are taking the average over the possible outcomes, which is denoted by 〈·〉O.
One can repeat the two-stage problem for T times to obtain a sequence of T observations:
each time an optimal sign is chosen for observation followed by a real observation, which
reveals the true value of the observed sign.
In a multistage version of the problem, we want to find an optimal sequence of decisions
OT = {j1, · · · , jT}, which maximizes the following objective functional of the observed
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signs: E [OT ] ≡
∑T
t=1〈DP (jt)〉O. Here, at each step, the ”observed” sign takes a value that
is sampled from the associated marginal probability P (Sj). This probability depends on the
model which we are working with. Note that here we are interested in finding an optimal
sequence of observations at the beginning of the process before doing any real observation. In
other words, in such a multistage problem, we are doing an ”extrapolation” or ”simulation”
of the observation process without performing any real observation. In practice, however,
we may fix the sequence of observations by a decimation algorithm: i.e., we repeat the
multistage problem for T times, where each time we observe the first sign suggested by the
output sequence, and reduce the number of to-be-observed sings by one.
In the following, we consider only simple approximations of the multistage problem; first
we reduce the difficult multistage problem to simpler two-stage problems. More precisely,
at each time step, we choose an unobserved sign jt, which results to the largest disease
polarization 〈DP (jt)〉O, for observation (greedy strategy). Then, we consider two cases: (I)
we perform a real observation to reveal the true value of the suggested sign for observation,
(II) we treat the suggested sign variable for observation as a stochastic variable with values
that are sampled from the associated marginal probability.
Let us start from the case in which we observe the true values of the signs chosen for
observation. Once again, we take the exponential benchmark model given by Eq. 12 as the
true model. We use the conditional marginals extracted from this true model to construct
the simple one-disease-one-sign (D1S1) and two-disease-one-sign (D2S1) models. Suppose
that we are given a disease hypothesis D and the associated symptoms S∗(D). We start
from a few randomly chosen observed sings from the set of symptoms. Then, at each time
step t, we compute the inferred sign probabilities P (Sj), and use the greedy strategy to
choose an unobserved sign for observation. The observed sign at each step takes the true
value given by S∗(D). To see how much the disease probabilities obtained from the models
are correlated with the true hypothesis D, after each observation, we compute the following
overlap function (or ”disease likelihood”):
DL(t) ≡ 1
ND
∑
a
(2Da − 1)
(
P (Da = 1)− 1
2
)
. (14)
Besides the magnitude, our decisions also affect the way that the above quantity behaves
with the number of observations.
In Fig. 3 we see how the above overlap function, DL(t), behaves for cases in which
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FIG. 3. Overlap of the inferred disease marginals with the true hypothesis for the exponential
benchmark model. The data are for the cases in which only one (a) or two (b) diseases are present.
The model parameters are obtained from the conditional marginals of the true model. There are
ND = 5 diseases, NS = 20 signs, and the algorithm starts with NO = 3 observed signs for a
randomly selected hypothesis D. An unobserved sign is chosen for observation by the greedy (G)
or random strategy using the inferred probabilities, and the observed sign takes the true value
given by S∗(D). The data are results of averaging over 1000 independent realizations of the true
model and the observation process.
only one or two diseases are present in D (see also Appendix C). For comparison, we also
show the results obtained by a random strategy, where an unobserved sign is chosen for
observation randomly and uniformly from the subset of unobserved signs. The number
of sign/disease variables here is small enough to allow for an exact computation of all the
marginal probabilities. It is seen that both the D1S1 and D2S1 models work very well when
only one disease is present and all the other diseases are absent. The D1S1 model already
fails when two diseases are present in the hypothesis, whereas the other model can still find
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the right diseases. However, we observe that even the D2S1 model gets confused when
there are more than two diseases in the hypothesis; in such cases, we would need to consider
more sophisticated models with interactions involving more than two diseases. Moreover, we
observe that the difference in the performances of the greedy and random strategies decreases
as the number of involved diseases increases. In Appendix C, we observe similar behaviors
for a more complex benchmark model Ptrue(S|D) ∝ 1/(1+H(S,S∗(D))), including also the
sign-sign interactions.
Next, we consider the case of simulating the diagnosis process without doing any real ob-
servation. Here, we assume that an observed sign takes a value which is sampled from the as-
sociated marginal probability P (Sj) at that time step. For comparison with the greedy strat-
egy, we also introduce two other strategies for choosing an unobserved sign for observation.
A naive strategy is to choose the most positive (MP) sign jmax = argmaxj{P (Sj = +1)} for
observation (MP strategy); jmax is the sign with the maximum probability of being positive.
In the early stages of the diagnosis, this probability is probably close to zero for most of the
signs. So, it makes sense to choose the most positive sign for observation to obtain more
information about the diseases. A more complicated strategy works by first computing the
conditional probabilities P (Sj|DML) for the maximum likelihood hypothesis DML, and then
selecting the most positive sign for observation (MPD strategy).
To have a more general comparison of the constructed models, in the following, we assume
that the model parameters (Ka,abi , and K
a,ab
ij ) are iid random numbers uniformly distributed
in an appropriate interval of real numbers. The leaky couplings are set to K0i = −1, which
correspond to small sign probabilities P (Si = 1|nodisease) ≃ 0.05. We assume that all the
possible one-disease and two-disease interaction factors are present in the models. Moreover,
inside each factor we have all the possible two-sign interactions in addition to the local sign
fields. As before, the prior disease probabilities P0(Da) are uniform probability distributions.
Figure 4 shows the performances for different models and strategies with a small number
of sign/disease variables. Here, the ”disease likelihood” gives the overlap of the disease
probabilities with the maximum likelihood hypothesis DML of the models. Moreover, all
the quantities are computed exactly. We see that in this case the average performance of
the greedy strategy is close to that of the MPD strategy at the beginning of the process.
For larger number of observations, the greedy performance degrades and approaches that of
the MP strategy.
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FIG. 4. Diagnostic performance of the models vs the number of observations for a small number of
sign/disease variables. (top) The exact disease-polarization (a) and disease-likelihood (b) obtained
by the MP strategy in the one-disease-one-sign (D1S1), two-disease-one-sign (D2S1), one-disease-
two-sign (D1S2), and two-disease-two-sign (D2S2) models. There are ND = 5 diseases, NS = 20
signs, and the algorithm starts with NO = 4 observed signs with positive values. The couplings
in the interaction factors are iid random numbers distributed uniformly in the specified intervals:
K0i = −1,Ka,abi ∈ (−1,+1),Ka,abij ∈ (−1,+1)/
√
NS . (bottom) Comparing the exact polarization
(c) and likelihood (d) of the diseases obtained by the MP, greedy (G), MPD, and random strategies,
for the D2S2 model. The data are results of averaging over 1000 independent realizations of the
model parameters.
The models with disease-disease and sign-sign interactions exhibit larger polarizations of
the disease probabilities and larger overlaps of the disease probabilities with the maximum-
likelihood hypothesis (see also Appendix C); we find that already the D2S1 model works
considerably better than theD1S1 model for disease-disease interactions of relative strengths
|Kabi /Kai | ≃ 0.3. A larger polarization means that we need a smaller number of observations
(medical tests) to obtain more definitive disease probabilities. A larger disease likelihood,
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here means that we are following the direction that is suggested by the most likely diseases.
In this sense, it appears that the two-sign/disease interactions could be very helpful in the
early stages of the diagnosis.
We checked that the above picture also holds if we start with different numbers of
observed signs, and if we double the magnitude of all the couplings. Similar behaviors
are observed also for larger problem sizes (see Appendix C). However, we see that for
strongly interacting models with much larger higher-order interactions, e.g., K0i = −1,
and Ka,abi ∈ (−2,+2), Ka,abij ∈ (−2,+2)/
√
NS, the MP strategy gets closer to the random
strategy. The fact that the MP strategy does not work well in this strongly correlated regime
was indeed expected. Here, the greedy strategy is working better than the MPD strategy,
and both are still performing better than the random strategy.
IV. DISCUSSIONS
In summary, we showed that considering the sign-sign and disease-disease interactions can
significantly change the statistical importance of the signs and diseases. More importantly,
we found that these higher-order correlations could be very helpful in the process of diagnosis,
especially in the early stages of the diagnosis. The results in Figs. 3 and 4 (and similar
figures in appendices) also indicate the significance and relevance of optimization of the
diagnosis procedure, where a good strategy could considerably increase the polarization
and likelihood of the diseases compared to the random strategy. In addition, we devised
an approximate inference algorithm with a time complexity that grows linearly with the
number of interaction factors connecting the diseases to the signs, and exponentially with
the maximum number of signs that are associated with such interaction factors. For clarity,
in this work, we considered only algorithms of minimal structure and complexity. It would be
straightforward to employ more accurate learning and inference algorithms in constructing
the models and inferring the statistical information from the models. The challenge is,
of course, to go beyond the heuristic and greedy algorithms that we used to study the
multistage stochastic optimization problem of deciding on the relevance and order of the
medical observations.
In this study, we considered very simple structures for the prior probability of the dis-
eases P0(D) and the leak probability of the signs P (S|nodisease). Obviously, depending
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on the available statistical data, we can obtain more reliable models also for these prob-
ability distributions. Alternatively, we could employ the maximum entropy principle to
construct directly the joint probability distribution of the sign and disease variables using
the joint marginal probabilities P (Si, Sj ;Da, Db). Note that, in practice, it is easier to ob-
tain this type of information than the stronger conditional probabilities P (Si, Sj|onlyDa)
and P (Si, Sj|onlyDa, Db). However, these measures are easier to model (or estimated by
experts), in the absence of enough observational data, because they present the sole effects
of single (or few) diseases.
The emphasize, in this study, was more on the diagnostic performances of the inferred
models than on the statistical significance of the selected models for a given set of clinical
data. A more accurate treatment of the model selection, for a finite collection of data,
accounts also the complexity of the models to avoid the over-fitting of the data. However,
we note that including the sign-sign and disease-disease interactions in the models is indeed
more natural than ignoring such correlations. Finally, to take into account the role of noises
in the model parameters, one should take the average of the objective function over the
probability distribution of the parameters, which is provided by the likelihood of the model
parameters.
Our proposed framework can be adapted to address assignment problems in cell biology,
immunology, and evolutionary biology [61–63, 65]. In contrast to clinical problems, here
data availability might be less of a problem in near future. Advances in genomics, transcrip-
tomics, proteomics and metabolomics promise high resolution molecular characterization of
cells. Intensive research has also been directed towards live single cell analysis which allows
characterization of pathways from an initial state to a final state [64]. Our approach can
be used to do early assignments and thus not only provides accuracy but also an improved
sensitivity for diagnostics at the cellular level.
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Appendix A: Details of the models
In this section, we give more details of the models, and show how the model parameters
are computed given the following true marginal probabilities:
Ptrue(Si|nodisease), ∀i, (A1)
Ptrue(Si, Sj|onlyDa), ∀i 6= j&a, (A2)
Ptrue(Si, Sj|onlyDa, Db), ∀i 6= j&a 6= b. (A3)
1. Case of one-disease-one-sign interactions: D1S1 model
The simplest model is obtained by considering only the one-disease factors besides the
leaky interactions. In addition, we assume that each factor contains only local sign fields,
i.e.,
φ0(S) = e
∑
iK
0
i Si, (A4)
φa(S|Da) = eDa
∑
iK
a
i Si , φab(S|Da, Db) = · · · = 1. (A5)
Here, the couplings are
K0i =
1
2
ln
(
Ptrue(Si = +1|nodisease)
Ptrue(Si = −1|nodisease)
)
, (A6)
Kai =
1
2
ln
(
Ptrue(Si = +1|onlyDa)
Ptrue(Si = −1|onlyDa)
)
−K0i . (A7)
Then the partition function reads
Z(D) =
∏
i
(
2 cosh(K0i +
∑
a
DaK
a
i )
)
. (A8)
The likelihood of diseases is given by
L(D|So) =
∏
i∈O
(
e(K
0
i +
∑
aDaK
a
i )Si
2 cosh(K0i +
∑
aDaK
a
i )
)
×
∏
a
P0(Da). (A9)
Note that after summing over the sign variables the disease variables become correlated and
the problem of computing the marginals is not straightforward. The same problem arises in
computation of the probability distribution of unobserved signs,
M(Su|So) =
∑
D
∏
i
(
e(K
0
i +
∑
aDaK
a
i )Si
2 cosh(K0i +
∑
aDaK
a
i )
)
×
∏
a
P0(Da). (A10)
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For the moment, we assume the number of involved variables ND,S are small enough to
do the above computations exactly. For larger number of variables, we have to resort to
an approximate algorithm. We will describe such an approximate algorithm later when we
consider more serious examples.
2. Case of two-disease-one-sign interactions: D2S1 model
Now we consider the more interesting case of one- and two-disease interaction factors.
Again, we assume that each factor contains only local sign fields, i.e.,
φ0(S) = e
∑
iK
0
i Si , (A11)
φa(S|Da) = eDa
∑
iK
a
i Si, (A12)
φab(S|Da, Db) = eDaDb
∑
iK
ab
i Si , φabc(S|Da, Db, Dc) = · · · = 1. (A13)
Here, the couplings are
K0i =
1
2
ln
(
Ptrue(Si = +1|nodisease)
Ptrue(Si = −1|nodisease)
)
, (A14)
Kai =
1
2
ln
(
Ptrue(Si = +1|onlyDa)
Ptrue(Si = −1|onlyDa)
)
−K0i , (A15)
Kabi =
1
2
ln
(
Ptrue(Si = +1|onlyDa, Db)
Ptrue(Si = −1|onlyDa, Db)
)
−K0i −Kai −Kbi . (A16)
Still, we can easily obtain the partition function
Z(D) =
∏
i
(
2 cosh(K0i +
∑
a
DaK
a
i +
∑
a<b
DaDbK
ab
i )
)
. (A17)
The likelihood reads
L(D|So) =
∏
i∈O
(
e(K
0
i +
∑
aDaK
a
i +
∑
a<bDaDbK
ab
i )Si
2 cosh(K0i +
∑
aDaK
a
i +
∑
a<bDaDbK
ab
i )
)
×
∏
a
P0(Da). (A18)
Similarly,
M(Su|So) =
∑
D
∏
i
(
e(K
0
i +
∑
aDaK
a
i +
∑
a<bDaDbK
ab
i )Si
2 cosh(K0i +
∑
aDaK
a
i +
∑
a<bDaDbK
ab
i )
)
×
∏
a
P0(Da). (A19)
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3. Introducing the two-sign interactions: D1S2 and D2S2 models
A more challenging model is obtained with the two-sign interactions
φ0(S) = e
∑
iK
0
i Si , (A20)
φa(S|Da) = eDa[
∑
iK
a
i Si+
∑
i<j K
a
ijSiSj ], (A21)
φab(S|Da, Db) = eDaDb[
∑
iK
ab
i Si+
∑
i<j K
ab
ij SiSj ], φabc(S|Da, Db, Dc) = · · · = 1. (A22)
Here, even computing the partition function is difficult, and from the beginning we have to
resort to approximations.
First of all, we need to obtain the couplings given the conditional probabilities,
P0(Si) ≡ Ptrue(Si|nodisease), (A23)
Pa(Si, Sj) ≡ Ptrue(Si, Sj|onlyDa), Pa(Si) ≡ Ptrue(Si|onlyDa), (A24)
Pab(Si, Sj) ≡ Ptrue(Si, Sj|onlyDa, Db), Pab(Si) ≡ Ptrue(Si|onlyDa, Db). (A25)
As before, the zero-order couplings are given by
K0i =
1
2
ln
(
P0(Si = +1)
P0(Si = −1)
)
. (A26)
To obtain the other couplings, we resort to the so-called independent-pair approximation
[43], where we assume
Pa(Si, Sj) ∝ eKaijSiSj+haijSi+hajiSj , Pa(Si) ∝ ehai Si (A27)
Pab(Si, Sj) ∝ eKabij SiSj+habij Si+habji Sj , Pab(Si) ∝ ehabi Si . (A28)
In this way we obtain,
Kaij =
1
4
ln
(
Pa(Si = +1, Sj = +1)Pa(Si = −1, Sj = −1)
Pa(Si = +1, Sj = −1)Pa(Si = −1, Sj = +1)
)
, (A29)
Kabij =
1
4
ln
(
Pab(Si = +1, Sj = +1)Pab(Si = −1, Sj = −1)
Pab(Si = +1, Sj = −1)Pab(Si = −1, Sj = +1)
)
−Kaij −Kbij , (A30)
and
Kai =
1
4
∑
j 6=i
ln
(
Pa(Si = +1, Sj = +1)Pa(Si = +1, Sj = −1)
Pa(Si = −1, Sj = −1)Pa(Si = −1, Sj = +1)
)
− (NS − 2)
2
ln
(
Pa(Si = +1)
Pa(Si = −1)
)
−K0i , (A31)
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FIG. 5. Probability of changing the most probable (MP) disease (a) and sign (b) variable in the
one-disease-one-sign (D1S1), two-disease-one-sign (D2S1), one-disease-two-sign (D1S2), and two-
disease-two-sign (D2S2) models. There are ND = 5 diseases, NS = 15 signs, and NO = 3 observed
signs with positive values. The couplings in the interaction factors are iid random numbers dis-
tributed uniformly in the specified intervals: K0i = −1,Ka,abi ∈ (−1,+1),Ka,abij ∈ (−1,+1)/
√
NS .
A noise of strength ǫ changes the couplings by δKa,abi ∈ (−ǫ,+ǫ), δKa,abij ∈ (−ǫ,+ǫ)/
√
NS . The
data have been obtained from 1000 independent realizations of the model parameters.
Kabi =
1
4
∑
j 6=i
ln
(
Pab(Si = +1, Sj = +1)Pab(Si = +1, Sj = −1)
Pab(Si = −1, Sj = −1)Pab(Si = −1, Sj = +1)
)
− (NS − 2)
2
ln
(
Pab(Si = +1)
Pab(Si = −1)
)
−K0i −Kai −Kbi . (A32)
One can find other approximation methods in the literature to address the above inverse
problem. For example, one can employ the exact fluctuation-response relations within the
Bethe approximation to obtain more accurate estimations for the marginal probability dis-
tribution of sign variables [36, 45].
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Note that the model parameters are usually noisy because they may come from an ap-
proximate learning algorithm with a finite collection of clinical data. Thus, it is important
to know how the noise strength affects the marginal sign/disease probabilities. In Fig.
5, we show how much the uncertainties in the model parameters are likely to change the
sign/disease with the highest probability of being positive/present. We see that this prob-
ability increases linearly with the relative strength of the noise in the model parameters
ǫ ≡ δK/K; for example, in a small model of ND = 5 diseases, NS = 15 signs with NO = 3
observed signs, a noise of strength ǫ = 0.1 changes the most probable sign/disease in nearly
%10 of the cases.
Appendix B: An approximate inference algorithm
In this section, we present an approximate way of computing the sign/disease marginal
probabilities. To be specific, we will focus on the two-disease-two-sign (D2S2) model.
We will consider the joint measure
P (S;D) = P (S|D)P0(D) ∝ e−H(S;D), (B1)
of the disease and sign variables. Here, we defined the energy function
H(S;D) ≡ −
∑
i
K0i Si −
∑
a
Da[
∑
i
Kai Si +
∑
i<j
KaijSiSj]−
∑
a<b
DaDb[
∑
i
Kabi Si +
∑
i<j
Kabij SiSj ] + lnZ(D)− lnP0(D). (B2)
We may obtain the local probability marginals by a Monte Carlo (MC) algorithm for the
above system of interacting variables. But computing the above energy function for a given
configuration of the variables is computationally hard because computing Z(D) is in general
hard. Thus, to reduce the computation time we have to find a good approximation for the
partition function.
The exact expression for the partition function is
Z(D) =
∑
S
φ0(S)×
∏
a
φa(S|Da)×
∏
a<b
φab(S|Da, Db), (B3)
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which in terms of the couplings reads
Z(D) =
∑
S
e
∑
i hi(D)Si+
∑
i<j Jij(D)SiSj , (B4)
hi(D) ≡ K0i +
∑
a
DaK
a
i +
∑
a<b
DaDbK
ab
i , (B5)
Jij(D) ≡
∑
a
DaK
a
ij +
∑
a<b
DaDbK
ab
ij . (B6)
We are going to use the Bethe approximation to find an estimation for the above partition
function [34, 46, 47]. More precisely, in this approximation, we assume that the interaction
graph of the variables (defined by the couplings Jij) is a tree graph. We know how to
compute exactly and efficiently the local marginal probabilities and the partition function
in tree interaction graphs. The fact that there is no loop in a tree graph allows us to write
the marginal probability of a variable in terms of the cavity probabilities of the neighboring
variables, computed in the absence of the interested variable. These cavity probabilities are
the main quantities of the Bethe approximation. Here, e.g., we need to compute the cavity
marginals µi→j(Si), giving the probability of value Si for sign i in the absence of sign j. The
Bethe equations governing these cavity marginals are the following recursive equations [34]:
µi→j(Si) =
1
zi→j
ehiSi
∏
k 6=i,j
(∑
Sk
eJikSiSkµk→i(Sk)
)
, (B7)
where zi→j is a normalization constant. We can solve these equations by iteration starting
from random initial cavity marginals; the cavity marginals are updated according to the
above equations in a random and sequential way, until the algorithm converges. Then, we
use these stationary cavity marginals to compute the local probabilities and the partition
function [34].
In this way, for the partition function within the Bethe approximation, we obtain
Z(D) ≃ e
∑
i ∆i(D)−
∑
i<j ∆ij(D), (B8)
e∆i(D) ≡
∑
Si
ehiSi
∏
j 6=i

∑
Sj
eJijSiSjµj→i(Sj)

 , (B9)
e∆ij(D) ≡
∑
Si,Sj
eJijSiSjµi→j(Si)µj→i(Sj). (B10)
Notice that here the cavity marginals µi→j(Si) depend implicitly on the disease variables.
Now, we can compute efficiently an approximate change in the energy function H(S;D)
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when a disease variable is chosen for updating in a Monte Carlo algorithm. In the same way,
we may find an estimate of the likelihood of diseases by
L(D|So) = Z(D|S
o)
Z(D)
P0(D), (B11)
where
Z(D|So) =
∑
Su
φ0(S)×
∏
a
φa(S|Da)×
∏
a<b
φab(S|Da, Db), (B12)
can be estimated within the Bethe approximation, as we did for Z(D), but with fixed values
for the observed signs. This approximate expression for the likelihood is useful to find the
most likely diseases DML maximizing the likelihood.
Finding the maximum likelihood hypothesis DML, and obtaining good estimations for
the probability marginals of P (S;D) could be still very time consuming for a large number
of variables and frustrating energy functions. In the following, we will utilize the Bethe
approximation to estimate the above marginal probabilities.
1. Belief propagation equations
The interaction factors associated to diseases a and (ab) are
φa = exp
(
Da[
∑
i
Kai Si +
∑
i<j
KaijSiSj]
)
, (B13)
φab = exp
(
DaDb[
∑
i
Kabi Si +
∑
i<j
Kabij SiSj]
)
, (B14)
respectively. Let us label the above interactions with α ∈ {a, b, . . . , (ab), (ac), . . . } and use
φα(S
α|Dα) for the corresponding interaction factors. We represent the subset of sign and
disease variables in an interaction factor with ∂Sα and ∂Dα. The subset of interaction
factors depending on sign i and disease a are denoted by ∂i and ∂a, respectively. We will
assume that the resulting interaction graph is sparse, that is the numbers of interaction
factors (Ma,Mab) are small compared to NS, and the numbers of sign variables involved in
the interaction factors (ka, kab) are of order one. We take νi→α(Si) for the probability of
having value Si for sign i in the absence of interaction factor α. Similarly, define the cavity
probabilities νa→α(Da). In the Bethe approximation, we write approximate expressions for
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these cavity marginals in terms of the messages received from the other interaction factors
in the system [34, 47]. More precisely,
νi→α(Si) ∝ eK0i Si
∏
β∈∂i 6=α
Ψβ→i(Si), (B15)
νa→α(Da) ∝ P0(Da)
∏
β∈∂a6=α
Ψβ→a(Da)ΨZ→a(Da). (B16)
Note that the equation for νi→α(Si) gives the cavity marginal for an unobserved sign; the
cavity marginals of observed signs are fixed to values determined by the observations. The
cavity messages received from the interaction factors are given by
Ψα→i(Si) ∝
∑
{Da:a∈∂Dα}
∑
{Sj :j∈∂Sα\i}
φα(S
α|Dα)
∏
a∈∂Dα
νa→α(Da)
∏
j∈∂Sα\i
νj→α(Sj), (B17)
Ψα→a(Da) ∝
∑
{Db:b∈∂Dα\a}
∑
{Sj :j∈∂Sα}
φα(S
α|Dα)
∏
b∈∂Dα\a
νb→α(Db)
∏
j∈∂Sα
νj→α(Sj). (B18)
It remains to write the cavity marginals related to the partition function Z(D),
νa→Z(Da) ∝ P0(Da)
∏
α∈∂a
Ψα→a(Da), (B19)
ΨZ→a(Da) ∝
∑
{Db:b6=a}
e− lnZ(D)
∏
b6=a
νb→Z(Db). (B20)
The main difficulty comes from the last equation, where one has to sum over all possible
values of the disease variables and compute Z(D) for each configuration. We already know
how to compute the partition function by the Bethe approximation. But, the sum over the
disease variables grows exponentially with the number of variables. A naive approximation
to get around this complexity is obtained by a Bethe factorization of the partition function;
this is a nonnegative function of the disease variables, therefore, up to a normalization
constant, it can be interpreted as a probability measure of the associated variables. Suppose
µa(Da) and µα(D
α) are the local probability marginals of this measure. Then we may
approximate the partition function (up to a constant multiplication factor) by
Z(D) ∝
∏
a
µa(Da)
∏
α
(
µα(D
α)∏
a∈∂Dα
µa(Da)
)
. (B21)
Note that, we can obtain approximate expressions for the above local marginals by solving
the above equations without considering the interactions induced by the partition function
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FIG. 6. The sign (a) and disease (b) marginal probabilities computed by the approximate belief
propagation algorithm for a single instance of the two-disease-two-sign (D2S2) model. The pa-
rameters are ND = 20, NS = 200, NO = 10,Ma = 20,Mab = 40, ka = 6, kab = 3. Each factor
includes all the possible two-sign interactions in addition to the local sign fields. The couplings are
iid random numbers distributed uniformly in the specified intervals: K0i = −1,Ka,abi ∈ (−1,+1),
and Kaij ∈ (−1,+1)/
√
ka,K
ab
ij ∈ (−1,+1)/
√
kab. The sign and disease variables in each factor are
chosen randomly with a uniform probability.
Z(D). Moreover, the above approximation can be improved by considering the higher-order
marginals in the above factorization.
Now that Z(D) is factorized, we do not need any longer the cavity messages introduced
in Eqs. B19 and B20. Instead, we will absorb the factors in the interaction factors φα,
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working with the modified interactions
φ˜a ≡ φa
µa(Da)
, (B22)
φ˜ab ≡ µa(Da)µb(Db) φab
µab(Da, Db)
. (B23)
In summary, within the above approximation of the partition function, we first solve the
following equations for the cavity marginals, considering the modified interactions,
νi→α(Si) ∝ eK0i Si
∏
β∈∂i 6=α
Ψ˜β→i(Si), (B24)
νa→α(Da) ∝ P0(Da)
∏
β∈∂a6=α
Ψ˜β→a(Da), (B25)
and
Ψ˜α→i(Si) ∝
∑
{Da:a∈∂Dα}
∑
{Sj :j∈∂Sα\i}
φ˜α(S
α|Dα)
∏
a∈∂Dα
νa→α(Da)
∏
j∈∂Sα\i
νj→α(Sj), (B26)
Ψ˜α→a(Da) ∝
∑
{Db:b∈∂Dα\a}
∑
{Sj :j∈∂Sα}
φ˜α(S
α|Dα)
∏
b∈∂Dα\a
νb→α(Db)
∏
j∈∂Sα
νj→α(Sj). (B27)
These equations are solved by iteration; we start from random initial messages, and update
the cavity marginals according to the above equations until the algorithm converges. Then,
we obtain the sign and disease marginal probabilities from similar equations, but taking into
account all the neighboring interactions, that is,
P (Si) ∝ eK0i Si
∏
α∈∂i
Ψ˜α→i(Si), (B28)
P (Da) ∝ P0(Da)
∏
α∈∂a
Ψ˜α→a(Da). (B29)
Figure 6 shows the sign and disease probabilities we obtain for the two-disease-two-sign
(D2S2) model with ND = 20 diseases, NS = 200 signs, and NO = 10 observed signs of
positive values. Here, we take a sparse interaction graph with Ma = 20 one-disease factors
and Mab = 40 two-disease factors connected randomly to ka = 6 and kab = 3 sign variables,
respectively. The quality of our approximation depends very much on the structure of
the interaction factors and strength of the associated couplings in the models. The Bethe
approximation is exact for interaction graphs that have a tree structure. It is expected to
work very well also in sparsely connected graphs, where the number of interaction factors
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FIG. 7. Relative errors of the disease (a) and sign (b) marginal probabilities computed by the
approximate belief propagation algorithm for the two-disease-two-sign (D2S2) model. The pa-
rameters are ND = 5, NS = 20, NO = 3,Ma = 5, kab = 2, with Mab and ka taking different
values. Each factor includes all the possible two-sign interactions in addition to the local sign
fields. The couplings are iid random numbers distributed uniformly in the specified intervals:
K0i = −1,Ka,abi ∈ (−1,+1), and Kaij ∈ (−1,+1)/
√
ka,K
ab
ij ∈ (−1,+1)/
√
kab. The sign and disease
variables in each factor are chosen randomly with a uniform probability.
(Ma,Mab) and the number of signs associated to an interaction factor (ka, kab) are small
compared to the total number of sign variables. This behavior is observed in Fig. 7, which
displays the relative errors in the marginal probabilities of sign/disease variables, obtained
by the above approximate algorithm. The time complexity of our approximate inference
algorithm grows linearly with the number of interaction factors, and exponentially with
the number of variables involved in such interactions; with ND = 500, NS = 5000,Ma =
500,Mab = 1000, ka = 10, kab = 5 the algorithm takes about one minute of CPU time on a
standard PC to compute the local marginals.
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Appendix C: Comparing the diagnostic performance of the models
As explained in the main text, we reduce the multistage problem of diagnosis to a sequence
of two-stage problems. At each step, we use a greedy or heuristic strategy to choose the next
sign for observation. We study two different cases depending on the values that are assigned
to the observed signs: (I) in a real observation we find the true value of the observed sign,
(II) in a simulation of the observation process, the value of observed sign j is sampled from
its marginal probability P (Sj). In this section, we present more details of the two cases.
1. Case I
Here, we need to know the true sign values, therefore, we choose a true model with a clear
association of symptoms to diseases. As the benchmark, we take the exponential conditional
probability,
Ptrue(S|D) = 1
Ztrue(D)
e−H(S,S
∗(D)), (C1)
where S∗(D) gives the symptoms of hypothesis D. We choose the symptoms randomly and
uniformly from the space of sign configurations. Here H(S,S′) =
∑NS
i=1(Si − S ′i)2/4 is the
Hamming distance (number of different signs) of the two sign configurations. As before,
we will take a factorized and unbiased prior disease probability P0(D). Note that there is
no sign-sign interaction in the above true model. Therefore, we need to consider only the
effects of disease-disease interactions, and study the D1S1 and D2S1 models. Let us assume
that we are given the true conditional marginals Ptrue(Si|nodisease), Ptrue(Si|onlyDa), and
Ptrue(Si|onlyDa, Db). From these information, we can exactly obtain the model parameters
K0i , K
a
i , and K
ab
i as described in Appendix A.
Let us take a single realization of the true model for a small number of sign/disease
variables. This allows us to compute exactly the conditional marginal probabilities P (Si =
+1|Da = 1) and P (Si = −1|Da = 0), which are known in the literature as sensitivity and
specificity, respectively. As Fig. 8 shows, both the probabilities are in average closer to the
true values in the D2S1 model.
Now, we consider a sequential process of T decisions and real observations; at each step
an unobserved sign is chosen for observation and the observed sign takes the true value, given
by the symptoms S∗(D) of the true hypothesis D. This hypothesis is selected randomly and
29
 0
 0.2
 0.4
 0.6
 0.8
 1
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
se
n
si
tiv
ity
sign
 0
 0.2
 0.4
 0.6
 0.8
 1
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
sp
ec
ific
ity
sign
True
D1S1
D2S1
FIG. 8. Sensitivity, P (Si = +1|Da = 1), and specificity, P (Si = −1|Da = 0), in the D1S1 and
D2S1 models for the exponential benchmark model. The data are for one of the diseases in a single
realization of the true model. The model parameters are obtained from the conditional marginals
of the exponential true model. Here we have ND = 5 diseases, NS = 20 signs.
uniformly at the beginning of the process. At each step, we compute the sign marginals
P (Sj) in the constructed models, and use the MP (or greedy) strategy to choose the next
observation. Figure 9 shows the RMS errors ∆D and ∆S in the marginal disease and sign
probabilities, respectively, during such a process. Here, we are using the MP strategy and
the errors are defined as follows,
∆D ≡
(
1
ND
∑
a
(P (Da = 1)− Ptrue(Da = 1))2
)1/2
, (C2)
∆S ≡
(
1
NU
∑
i∈U
(P (Si = 1)− Ptrue(Si = 1))2
)1/2
, (C3)
where U is the subset of unobserved signs with NU = |U |. Figure 10 displays the inferred
disease probabilities P (Da = 1) in the same process for cases in which only one or two
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FIG. 9. The RMS error in disease (a) and sign (b) marginal probabilities in the D1S1 and
D2S1 models for the exponential benchmark model. The model parameters are obtained from
the conditional marginals of the true model. There are ND = 5 diseases, NS = 20 signs, and
the algorithm starts with NO = 3 observed signs for a randomly selected hypothesis D. An
unobserved sign is chosen for observation by the MP strategy using the inferred sign probabilities,
and the observed sign takes the true value given by S∗(D). The data are results of averaging over
1000 independent realizations of the true model and the observation process.
diseases are present. It is seen that both the D1S1 and D2S1 models end up with the right
diagnosis when only one diseases is present (D1 = 1, D2 = D3 = · · · = 0). But, the D1S1
model fails when there are two diseases in the hypothesis (D1 = D2 = 1, D3 = D4 = · · · = 0),
whereas the other model can still find the right diseases. However, we find that even the
D2S1 model gets confused when there are more than two diseases in the hypothesis. Then,
we would need to consider more sophisticated models with interactions involving more than
two diseases.
To see the importance of sign-sign interactions, we consider another benchmark model
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FIG. 10. The inferred disease probabilities vs the number of observations for the exponential
benchmark model. The data are for the cases in which only one (a,b) or two (c,d) diseases are
present. The model parameters are obtained from the conditional marginals of the true model.
There are ND = 5 diseases, NS = 20 signs, and the algorithm starts with NO = 3 observed signs
for a randomly selected hypothesis D. An unobserved sign is chosen for observation by the MP
strategy using the inferred sign probabilities. The observed sign takes the true value given by
S∗(D). The data are results of averaging over 1000 independent realizations of the true model and
the observation process.
given by the following conditional probability:
Ptrue(S|D) = 1
Ztrue(D)
(
1
1 +H(S,S∗(D))
)
. (C4)
Given a disease hypothesis D and the associated symptoms S∗(D), we start from a few
number of randomly chosen observed sings from the set of symptoms S∗(D). At each step,
we compute the inferred sign probabilities P (Si) and use the greedy algorithm to choose an
unobserved sign for observation. The observed sign at each time step takes the true value
given by S∗(D). Figure 11 shows the overlap of the inferred probabilities P (Da = 1) with
the true hypothesis for cases in which only one or two diseases are present. For comparison,
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FIG. 11. Overlap of the inferred disease marginals with the true hypothesis for the power-law
benchmark models. The data are for the cases in which only one (a) or two (b) diseases are
present. The model parameters are obtained from the conditional marginals of the true model.
There are ND = 5 diseases, NS = 20 signs, and the algorithm starts with NO = 3 observed signs
for a randomly selected hypothesis D. An unobserved sign is chosen for observation by the greedy
(G) strategy using the inferred sign probabilities. The observed sign takes the true value given by
S∗(D). The data are results of averaging over 1000 independent realizations of the true model and
the observation process.
we also show the results obtained by the random strategy. The figure shows that we can
obtain higher overlaps between the inferred disease marginals and the true hypothesis by
considering the sign-sign interactions. Nevertheless, we find that even the D2S2 model fails
in cases with more than two diseases.
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2. Case II
Here, the model parameters are chosen randomly and uniformly in symmetric intervals
of real numbers; e.g., Ka,abi ∈ (−1,+1), Ka,abij ∈ (−1,+1)/
√
NS. The leaky couplings are
set to K0i = −1, corresponding to small sign probabilities P (Si = 1|nodisease) ≃ 0.05.
We assume that all the possible one-disease and two-disease interaction factors are present
in the models. Moreover, inside each factor we have all the possible two-sign interactions
in addition to the local sign fields; that is why we scale the two-sign couplings Ka,abij with
the inverse square root of the number of sign variables. The prior disease probabilities are
uniform P0(Da = 1) = 0.5.
We start from a small number of randomly selected observed signs with random values.
Then, at each step, we choose an unobserved sign for observation with stochastic findings
sampled from the associated probability distributions. The process is repeated 1000 times for
different realizations of the couplings and findings of the observations to obtain the average
polarization and likelihood of diseases. For reference, we also show the results that were
obtained by a random strategy, where an unobserved sign is chosen randomly and uniformly
for observation. In Fig. 12 we see that the average performance of the greedy strategy
changes from that of the MPD strategy for small number of observations to that of the MP
strategy for larger number of observations.
However, as Fig. 13 shows, for strongly correlated models with much larger higher-order
interactions, e.g., K0i = −1 and Ka,abi ∈ (−2,+2), Ka,abij ∈ (−2,+2)/
√
NS, the difference
between the performances of the most positive (MP) strategy and the random strategy
diminishes. Furthermore, here the greedy strategy performs better than the MP and MPD
strategies. The fact that such a heuristic algorithm does not work well in this regime was
indeed expected; it is this type of finding that makes strongly interacting systems interesting,
and in need for more elaborate methods and algorithms.
Finally, Fig. 14 displays the average polarization of disease probabilities obtained by
the approximate inference algorithm (BP) for much larger number of sign/disease variables.
Here, the maximum likelihood hypothesis (DML in the MPD strategy) is simply approxi-
mated by the most probable diseases suggested by the marginal disease probabilities. That
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FIG. 12. Diagnostic performance of the models vs the number of observations for different strate-
gies. The exact disease-polarization (DP) and disease-likelihood (DL) obtained by the greedy,
MP, MPD, and random strategies in the one-disease-one-sign (D1S1, (a)-(b)), two-disease-one-
sign (D2S1, (c)-(d)), and one-disease-two-sign (D1S2, (e)-(f)) models. There are ND = 5 dis-
eases, NS = 20 signs, and the algorithm starts with NO = 4 observed signs with positive values.
The coupling constants are iid random numbers distributed uniformly in the specified intervals:
K0i = −1,Ka,abi ∈ (−1,+1),Ka,abij ∈ (−1,+1)/
√
NS. The data are results of averaging over 1000
independent realizations of the model parameters.
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FIG. 13. Diagnostic performance of the models vs the number of observations for larger couplings.
(top) The exact disease polarization (a) and disease likelihood (b) obtained by the MP strategy
in the one-disease-one-sign (D1S1), two-disease-one-sign (D2S1), one-disease-two-sign (D1S2),
and two-disease-two-sign (D2S2) models. There are ND = 5 diseases, NS = 20 signs, and the
algorithm starts with NO = 4 observed signs with positive values. The couplings in the interaction
factors are iid random numbers distributed uniformly in the specified intervals: K0i = −1,Ka,abi ∈
(−2,+2),Ka,abij ∈ (−2,+2)/
√
NS . (bottom) Comparing the exact polarization (c) and likelihood
(d) of the diseases obtained by the greedy, MP, MPD, and random strategies, for the D2S2 model.
The data are results of averaging over 1000 independent realizations of the model parameters.
is, we take Da = 0 if P (Da = 0) > 1/2, otherwise Da = 1.
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FIG. 14. Diagnostic performance of the models vs the number of observations for a larger number
of sign/disease variables. (a) The approximate disease-polarization (DP) obtained by the MP
strategy in the one-disease-one-sign (D1S1), two-disease-one-sign (D2S1), one-disease-two-sign
(D1S2), and two-disease-two-sign (D2S2) models. Here we have ND = 200 diseases, NS = 2000
signs, and the algorithm starts with NO = 50 observed signs with positive values. The graph
parameters are: Ma = 200,Mab = 0, ka = 8 in the D1S1 and D1S2 models, and Ma = 200,Mab =
1000, ka = 8, kab = 4 in the D2S1 and D2S2 models. The interaction factors in the D1S2 and
D2S2 models include all the possible two-sign interactions in addition to the local sign fields. The
couplings in the interaction factors are iid random numbers distributed uniformly in the specified
intervals: K0i = −1,Ka,abi ∈ (−1,+1),Ka,abij ∈ (−1,+1)/
√
ka,ab. (b) Comparing the approximate
polarization of the diseases obtained by the MP, MPD, and random strategies, for the D2S2 model.
The data are results of averaging over 100 independent realizations of the model parameters.
42
